Obesity and diabetic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Metabolic Diseases

Background:

• Obesity and diabetes are leading global causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD).
• Metabolic syndrome components, including obesity, diabetes, and hypertension, are interconnected and accelerate renal disease progression.
• These conditions initiate renal vasodilation, glomerular hyperfiltration, and albuminuria, culminating in glomerulopathy.

Purpose of the Study:

• To highlight the critical role of obesity and diabetes in renal disease.
• To emphasize the need for early intervention in managing weight, hyperglycemia, and hypertension.
• To underscore the necessity for novel therapeutic strategies against obesity- and diabetes-related kidney disease.

Main Methods:

• Review of existing studies on metabolic syndrome and renal disease.
• Analysis of the multifactorial pathways contributing to glomerulopathy.
• Examination of the impact of hypertension on disease progression.

Main Results:

• Obesity and diabetes are primary drivers of CKD and ESRD.
• Combined metabolic factors exacerbate renal pathology, leading to progressive kidney damage.
• Untreated hypertension significantly worsens renal disease, potentially leading to ESRD.

Conclusions:

• Early management of obesity, hyperglycemia, and hypertension is essential for kidney health.
• Novel therapeutic approaches are urgently required to combat the high morbidity and mortality of obesity- and diabetes-related kidney disease.
• Integrated management strategies are imperative for addressing the global burden of metabolic-driven renal disease.